financetom
Business
financetom
/
Business
/
Oil and gas firm Granite Ridge's Q3 adjusted profit misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil and gas firm Granite Ridge's Q3 adjusted profit misses estimates
Nov 6, 2025 3:46 PM

Overview

* Granite Ridge Q3 adjusted EPS misses analyst expectations

* Company reports 27% increase in daily production to 31,925 Boe per day

* Granite Ridge issues $350 mln senior unsecured notes, enhancing liquidity

Outlook

* Granite Ridge expects 2025 production between 31,000 and 33,000 Boe per day

* Company projects 2025 total capital expenditures of $400 mln to $420 mln

* Granite Ridge anticipates 2025 lease operating expenses of $6.25 to $7.25 per Boe

Result Drivers

* PRODUCTION GROWTH - Daily production increased 27% to 31,925 Boe per day, driven by strong well performance in multiple basins

* CAPITAL INVESTMENTS - Invested $64 mln in development and $16.5 mln in acquisitions to capture high-quality drilling opportunities

* OPERATED PARTNERSHIPS - Strong performance from Operated Partnership platform, particularly in the Permian Basin, drove operational excellence

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Oil $112.70

and mln

Natural

Gas

Sales

Q3 Miss $0.09 $0.12 (4

Adjusted Analysts

EPS )

Q3 Miss $11.80 $21.49

Adjusted mln mln (4

Net Analysts

Income )

Q3 Miss $78.60 $81.88

Adjusted mln mln (5

EBITDA Analysts

)

Q3 $77.80

Adjusted mln

Free

Cash

Flow

Q3 $0.11

Dividend

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the oil & gas exploration and production peer group is "buy"

* Wall Street's median 12-month price target for Granite Ridge Resources Inc ( GRNT ) is $6.90, about 21.7% above its November 6 closing price of $5.40

* The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CrowdStrike Expands Partnership With NTT Data
CrowdStrike Expands Partnership With NTT Data
Mar 17, 2025
05:18 AM EDT, 03/17/2025 (MT Newswires) -- CrowdStrike Holdings ( CRWD ) and NTT Data said Monday they have expanded their partnership to combine NTT's managed cybersecurity services with the CrowdStrike Falcon cybersecurity platform. The companies said the move is expected to provide customers with advanced threat detection and response, among other features. ...
Fast-fashion retailer Forever 21 files for bankruptcy again
Fast-fashion retailer Forever 21 files for bankruptcy again
Mar 17, 2025
* US operating company files for Chapter 11 bankruptcy * Forever 21 will conduct liquidation sales for its stores * US stores and website remain open, international stores unaffected (Changes dateline, adds background, comment from CFO in paragraph 5) By Nicholas P. Brown March 17 (Reuters) - Fast-fashion retailer Forever 21's U.S. operating company on Sunday filed for Chapter 11...
UBS says
UBS says "ill-informed" Swiss debate feeding uncertainty
Mar 17, 2025
ZURICH (Reuters) - UBS on Monday said frequently ill-informed public debate about potential risks from its business activities and size has created uncertainties going into 2025 as Switzerland grapples with how to regulate the country's biggest bank. UBS is facing stricter new banking rules since it expanded through the acquisition of Credit Suisse in 2023 when its old rival collapsed...
Acrivon Therapeutics Names Adam Levy as CFO
Acrivon Therapeutics Names Adam Levy as CFO
Mar 17, 2025
05:22 AM EDT, 03/17/2025 (MT Newswires) -- Acrivon Therapeutics ( ACRV ) said Friday in a Form 8-K filing with the US Securities and Exchange Commission that it has appointed Adam Levy as chief financial officer succeeding Rasmus Holm-Jorgensen, effective April 1. Levy has served the company as senior vice president since July 2023. Holm-Jorgensen will step down from the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved